Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optical quality of the eye after glaucoma combination ophthalmic solutions: randomized double-masked crossover trial
jRCTs051240001Active, not recruiting
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of brimonidine, brinzolamide and timolol in Glaucoma (2 arms). Primary endpoint: Change in higher-order aberrations at 1 minute. Started Apr 2024; status: active, not recruiting.
02
Drugs
brimonidinebrinzolamidetimolol
03
Conditions
Glaucoma
Beyond the preview
Go deeper on jRCTs051240001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs051240001.